Senior insider sale
PRESIDENT AND CEO at PUMA BIOTECHNOLOGY, INC. — senior position signals high conviction
$364.0K
44.06K shares
What this filing means
AUERBACH ALAN H plans to sell 44.06K shares of PUMA BIOTECHNOLOGY, INC. valued at approximately $364.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/6/2026ACC: 0001959173-26-005126
DirectorOfficer10% Owner· PRESIDENT AND CEO
Since Jul 2018
44.06K
Shares to sell
$364.0K
Approx. market value
44.06K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
7/1/2026
44.06KTotal acquired44.06K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/1/2026 | Restricted Stock Vesting Compensation | 44.06K | — |
| Total | 44.06K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
44.06K
Market value
$364.0K
7/6/2026
Total
Units
44.06K
Value
$364.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/6/2026 | 44.06K | $364.0K | NASDAQ | Planned |
| Total | 44.06K | $364.0K | ||